- Home
- FLUX vs HOOK Comparison
FLUX vs HOOK Comparison
Compare FLUX & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- HOOK
- Stock Information
- Founded
- FLUX N/A
- HOOK 2011
- Country
- FLUX United States
- HOOK United States
- Employees
- FLUX N/A
- HOOK N/A
- Industry
- FLUX Industrial Machinery/Components
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- HOOK Health Care
- Exchange
- FLUX Nasdaq
- HOOK Nasdaq
- Market Cap
- FLUX 20.2M
- HOOK 18.1M
- IPO Year
- FLUX N/A
- HOOK 2019
- Fundamental
- Price
- FLUX $1.64
- HOOK $1.06
- Analyst Decision
- FLUX Strong Buy
- HOOK Buy
- Analyst Count
- FLUX 3
- HOOK 4
- Target Price
- FLUX $6.33
- HOOK $10.67
- AVG Volume (30 Days)
- FLUX 85.0K
- HOOK 48.3K
- Earning Date
- FLUX 03-20-2025
- HOOK 05-08-2025
- Dividend Yield
- FLUX N/A
- HOOK N/A
- EPS Growth
- FLUX N/A
- HOOK N/A
- EPS
- FLUX N/A
- HOOK N/A
- Revenue
- FLUX $60,789,000.00
- HOOK $43,946,000.00
- Revenue This Year
- FLUX $11.85
- HOOK N/A
- Revenue Next Year
- FLUX $13.10
- HOOK N/A
- P/E Ratio
- FLUX N/A
- HOOK N/A
- Revenue Growth
- FLUX N/A
- HOOK 118.32
- 52 Week Low
- FLUX $1.15
- HOOK $0.98
- 52 Week High
- FLUX $5.46
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- FLUX 51.09
- HOOK 29.63
- Support Level
- FLUX $1.53
- HOOK $1.06
- Resistance Level
- FLUX $2.20
- HOOK $1.24
- Average True Range (ATR)
- FLUX 0.24
- HOOK 0.08
- MACD
- FLUX 0.03
- HOOK 0.01
- Stochastic Oscillator
- FLUX 47.05
- HOOK 10.34
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.